Back/Eversource Energy: Asahi Intecc USA Launches Innovative Tools in Gastrointestinal Market
USA·October 24, 2025·es

Eversource Energy: Asahi Intecc USA Launches Innovative Tools in Gastrointestinal Market

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Asahi Intecc USA launches innovative endoscopic tools, Tornus ES and Fielder 18, enhancing gastrointestinal procedures.
  • The Tornus ES and Fielder 18 improve precision in stricture dilation and biliary duct cannulation for GI specialists.
  • Asahi's expansion into the GI market reflects a strategy to diversify offerings and meet growing healthcare demands.

### Asahi Intecc USA Expands into Gastrointestinal Market with Innovative Tools

Asahi Intecc USA marks a significant milestone by entering the U.S. gastrointestinal (GI) market with the launch of two cutting-edge endoscopic tools, the Tornus ES and Fielder 18. This strategic move leverages Asahi’s established expertise in cardiovascular and neurovascular interventions to enhance gastroenterological procedures. The Tornus ES, an endoscopic dilator, is particularly designed for stricture dilation within the pancreaticobiliary system. It features a dual-coil structure made from stainless steel and polymer materials, available in two guidewire diameters of 0.018" and 0.025". The device operates via a rotary mechanism, allowing physicians to precisely dilate target sites while its hydrophilic coating ensures smooth advancement through the anatomy.

The Fielder 18 complements the Tornus ES by facilitating selective cannulation of biliary ducts, including the common bile duct and pancreatic duct. This tool is engineered to enhance the placement of diagnostic and therapeutic devices, addressing persistent challenges in procedures such as endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP). Asahi Intecc's entry into the GI sector not only reflects its commitment to innovation but also aims to empower GI specialists with improved control and confidence during complex interventions. Shaun Mazur, GI National Sales Manager at Asahi Intecc USA, expresses excitement over these new products, emphasizing their potential to elevate procedural outcomes and enhance the standard of care within gastrointestinal medicine.

These developments underscore the growing intersection of technology and healthcare, particularly in specialized fields such as gastroenterology. Asahi Intecc's innovative tools are expected to significantly contribute to improved patient outcomes and operational efficiency in GI practices. The introduction of the Tornus ES and Fielder 18 aligns with a broader trend in the medical device industry that prioritizes precision and effectiveness, addressing the evolving needs of healthcare providers and their patients.

In addition to these innovations, Asahi Intecc’s expansion into the GI market signifies a broader strategy to diversify its product offerings and tap into the growing demand for advanced medical devices. As healthcare continues to evolve, the integration of reliable technologies like those introduced by Asahi holds the potential to redefine standards in patient care. The launch not only showcases the company's commitment to quality but also positions it well for future growth in a competitive landscape.